Skip to main content
    C

    Cumberland Pharmaceuticals Inc (CPIX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $5.80
    +0.59 (+11.32%)

    Market Cap: $88.16M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Cumberland Pharmaceuticals Inc (CPIX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cumberland Pharmaceuticals (CPIX) has a market cap of $88.16M and an enterprise value of $7.58M. It kept 273.70% of revenue as net income over the last 12 months. Its dividend yield is 25.86%.

    Total Valuation

    Enterprise value is 91.41% below the market cap, as cash exceeds debt.

    Market Cap$88.16M
    Enterprise Value$7.58M
    Latest price (Nov 17, 2026)$5.80

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Jul 23, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Last Ex-Dividend DateJul 23, 2026
    Last Payment DateJul 31, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.05% in the quarter ended Sep 30, 2026 and grew 3.28% a year over 2 years.

    Shares Outstanding14.99M
    Shares Change (YoY)+0.21%
    Shares Change (QoQ)+0.05%
    Share Count Growth (2Y CAGR)+3.28%

    Valuation Ratios

    Sales and book value multiples are 3.5x and 1.2x. Its year-end P/S ranged from 0.6x to 3.2x from 2016 to 2025.

    P/S Ratio3.5x
    P/B Ratio1.2x
    P/TBV Ratio1.2x

    Valuation history and multiples

    Enterprise Valuation

    EV / Earnings0.1x
    EV / Sales0.3x

    Price Statistics

    The stock is up 232.30% over 52 weeks and trades 11.99% below its 50-day average.

    Beta (1Y)0.55
    52-Week Change+232.30%
    1-Month Change-13.43%
    3-Month Change-24.18%
    6-Month Change+29.61%
    5-Year Change+74.35%
    10-Year Change-1.26%
    Total Return (1Y)+404.18%
    Total Return (3Y CAGR)+61.31%
    Total Return (5Y CAGR)+22.44%
    Return vs SPY (1Y)+244.36%
    Max Drawdown (1Y)-52.95%
    Max Drawdown (3Y)-71.93%
    Sharpe Ratio (1Y)1.10
    Correlation with SPY (1Y)0.07
    50-Day Average$6.59
    200-Day Average$5.08
    52-Week Range$1.15 to $9.28
    RSI (14 Days)49.1
    Average Volume (20 Days)238.81K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.05x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.05x
    Quick Ratio3.04x
    Debt / Equity0.00x
    Interest Coverage-47.02x

    Returns and Efficiency

    Return on equity is 94.87% over the last 12 months, against a 5-year average of -17.02%.

    Return on Equity (ROE)94.87%
    Return on Assets (ROA)60.46%
    ROE (5Y Average)-17.02%
    ROA (5Y Average)-6.07%
    ROIC (5Y Average)-13.13%
    Asset Turnover0.28x
    Inventory Turnover139.48x
    Receivables Turnover1.94x
    Cash Conversion Cycle-1385 days

    Scores

    CPIX has an Altman Z-Score of 2.19, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score2.19
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $25.13M over the last 12 months is up 10.71% from the 12 months before.

    Revenue$25.13M
    Revenue Growth (YoY)+10.71%
    Gross Profit$20.96M
    Operating Income-$9.60M
    Pretax Income-$8.75M
    Net Income$68.79M
    EBITDA-$6.42M
    Reported EPS (TTM)-$0.58

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 63.73% of the $113.78M in total assets.

    Cash and Equivalents$80.58M
    Total Debt$0
    Net Cash$80.58M
    Net Cash Per Share$5.38
    Working Capital$70.23M
    Shareholder Equity$72.51M
    Book Value Per Share$4.84
    Tangible Book Value$72.47M
    Tangible Book Per Share$4.83
    Total Assets$113.78M
    Total Liabilities$41.60M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Margins

    The operating margin is -38.19%, against a 5-year average of -16.47%.

    Gross Margin83.39%
    Operating Margin-38.19%
    Pretax Margin-34.81%
    Net Margin273.70%
    EBITDA Margin-25.54%
    Gross Margin (5Y Average)81.22%
    Operating Margin (5Y Average)-16.47%
    Net Margin (5Y Average)-12.58%

    Growth

    Revenue grew 1.95% a year over 3 years.

    Revenue Growth (3Y CAGR)+1.95%
    Revenue Growth (5Y CAGR)+3.52%
    FCF Growth (3Y CAGR)-16.66%
    FCF Growth (5Y CAGR)-1.73%
    Book Value Per Share Growth (2Y CAGR)-10.79%
    Tangible Book Per Share Growth (2Y CAGR)+96.62%

    Revenue and profit by year

    Dividends and Yields

    CPIX pays out 32.69% of earnings as dividends.

    Dividend Per Share (Annual)$1.50
    Dividend Yield25.86%
    Payout Ratio32.69%

    Peer Position

    Against 6 similar companies, CPIX has the highest P/S.

    P/S Ratio3.5x vs 1.0x median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.71% vs -1.48% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CPIX

    What is CPIX's market cap?

    Cumberland Pharmaceuticals has a market cap of $88.16M. Its enterprise value, which adds debt and subtracts cash, is $7.58M.

    How many shares of CPIX are outstanding?

    Cumberland Pharmaceuticals has 14.99M shares outstanding. The count is up 0.21% from a year earlier.

    Does CPIX pay a dividend?

    Yes. Cumberland Pharmaceuticals pays $1.50 a share a year, a dividend yield of 25.86%.

    How much debt does CPIX have?

    Cumberland Pharmaceuticals has $0 of total debt and $80.58M of cash and equivalents, a net cash position of $80.58M.